Profusa (PFSA) Return on Capital Employed (2022 - 2026)
Profusa's (PFSA) quarterly Return on Capital Employed came in at 113.3% in Q1 2026, up 7729.0% year-on-year from 1.45% in Q1 2025, and down 25.29% quarter-over-quarter from 151.65% in Q4 2025.
Profusa (PFSA) Return on Capital Employed (2022 - 2026) Analysis & Trends
Profusa's Return on Capital Employed history runs 5 years deep, the most recent figure standing at 113.3% for Q1 2026.
- On a quarterly basis, Return on Capital Employed rose 7729.0% year-over-year to 113.3% in Q1 2026; TTM through Mar 2026 was 113.3%, a 7729.0% increase from a year earlier, with the FY2025 full-year figure at 147.11%, up 13813.0% from the prior year.
- Return on Capital Employed declined to 113.3% in Q1 2026 per PFSA's latest filing, from 151.65% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 151.65% in Q4 2025 and bottomed at 798.11% in Q3 2025.
- The 5-year median for Return on Capital Employed is 10.01% (2023), against an average of 46.48%.
- Biggest YoY gain for Return on Capital Employed was 14597 bps in 2025; the steepest drop was 73316 bps in 2025.
- Year by year, Return on Capital Employed stood at 0.66% in 2022, then plunged by 3776 bps to 25.47% in 2023, then soared by 122 bps to 5.68% in 2024, then jumped by 2569 bps to 151.65% in 2025, then declined by 25 bps to 113.3% in 2026.
- Per Business Quant, the three latest PFSA Return on Capital Employed figures stand at 113.3% (Q1 2026), 151.65% (Q4 2025), and 798.11% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 11.13% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 24.24% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 8.38% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 9.30% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Profusa | 23,566.40 | -351,433.60 | - | 113.30% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 113.30% |
| Dec 31, 2025 | 151.65% |
| Sep 30, 2025 | -798.11% |
| Jun 30, 2025 | 32.21% |
| Mar 31, 2025 | 36.01% |
| Dec 31, 2024 | 5.68% |
| Sep 30, 2024 | -64.95% |
| Jun 30, 2024 | -33.60% |
| Mar 31, 2024 | -26.81% |
| Dec 31, 2023 | -25.47% |
| Sep 30, 2023 | -18.54% |
| Jun 30, 2023 | -20.00% |
| Mar 31, 2023 | -1.47% |
| Dec 31, 2022 | -0.66% |